Well Told Grants

Federal grant recipients / Missouri

Federal grants to Senseion Therapeutics Inc

Saint Louis, Missouri · Small businesses · UEI V2KQH21BGKY5

Senseion Therapeutics Inc in Saint Louis, Missouri received $4.4 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was Cardiovascular Diseases Research, with $2.3 million. In fiscal 2025 it was awarded $1.0 million.

From USAspending.gov award records, updated November 7, 2026.

By year

Federal grants to Senseion Therapeutics Inc by fiscal year
Fiscal yearAwardsAmount
FY 20210$0
FY 20222$2.1 million
FY 20231$323,485
FY 20241$982,162
FY 20251$1.0 million

An award funded in several years counts in each of them, so yearly awards add up to more than the five-year total.

Programs that fund Senseion Therapeutics Inc

Every program, fiscal 2021 to 2025
ProgramAwardsAmount
Cardiovascular Diseases Research 93.8371$2.3 million
Diabetes, Digestive, and Kidney Diseases Extramural Research 93.8472$2.1 million

Awarding agencies

AgencyAwardsAmount
Department of Health and Human Services3$4.4 million

Largest awards

The 3 largest awards by money obligated in fiscal 2021 to 2025
AwardProgramFirst actionAmount
Targeting LRRC8 signaling to prevent & treat arterial thrombosis in type 2 diabetes - project summary cardiovascular disease (CVD) including stroke and myocardial infarction (MI), and type 2 diabetes (T2D) are overlapping global pandemics. Cvd is the most common cause of death in patients with T2D a
ASST_NON_R44HL169181_075 on USAspending
Cardiovascular Diseases ResearchAugust 30, 2023$2.3 million
Optimizing SWELL1 modulators to treat non-alcoholic steatohepatitis
ASST_NON_R44DK126600_075 on USAspending
Diabetes, Digestive, and Kidney Diseases Extramural ResearchApril 23, 2021$1.1 million
Targeting SWELL1 signaling to treat obesity-induced type 2 diabetes - project summary/abstract more than 100 million americans currently have diabetes or pre-diabetes, a condition that can lead to type 2 diabetes (T2D) within five years, and that vastly increases adverse cardiovascular events. T2D i
ASST_NON_R44DK121598_075 on USAspending
Diabetes, Digestive, and Kidney Diseases Extramural ResearchJanuary 31, 2022$990,929

Amounts are net obligations: money committed, minus any amounts taken back. They are not payments. See how our data works.

Questions people ask

How much federal grant money does Senseion Therapeutics Inc get?

$4.4 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.

Which agency gives Senseion Therapeutics Inc the most?

The Department of Health and Human Services, with $4.4 million in 3 awards.

What is Senseion Therapeutics Inc's largest federal grant?

$2.3 million under Cardiovascular Diseases Research, with its first action in the period on August 30, 2023. That counts only the money obligated in fiscal 2021 to 2025.

Which federal programs fund Senseion Therapeutics Inc?

Its largest are Cardiovascular Diseases Research and Diabetes, Digestive, and Kidney Diseases Extramural Research.

Other grant recipients in Saint Louis

Largest federal grant recipients in Missouri · Federal grants in Missouri